You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Litigation for Patent 8,669,290


✉ Email this page to a colleague

« Back to Dashboard


US Court Litigation for Patent: 8,669,290

Patent Trial and Appeal Board Cases for Patent 8,669,290

Patent Petitioner Status Filing Date Accorded Filing Date Patent Owner Trial Type Trial Number Decision Date Inventor Document Download
8,669,290 Metrics, Inc. ⤷  Subscribe 2014-06-26 06-26-2014 SENJU PHARMACEUTICAL CO., LTD. Inter partes review ⤷  Subscribe 02-19-2015 Shirou SAWA ⤷  Subscribe
8,669,290 InnoPharma Licensing, Inc. et al. ⤷  Subscribe 2015-03-19 03-19-2015 SENJU PHARMACEUTICAL CO., LTD. Inter partes review ⤷  Subscribe 08-07-2015 Shirou SAWA ⤷  Subscribe
8,669,290 Lupin Ltd. et al. ⤷  Subscribe 2015-04-23 04-23-2015 SENJU PHARMACEUTICAL CO., LTD. Inter partes review ⤷  Subscribe 10-27-2015 Shirou SAWA ⤷  Subscribe
>Patent >Petitioner >Status >Filing Date >Accorded Filing Date >Patent Owner >Trial Type >Trial Number >Decision Date >Inventor >Document Download

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.